Target Price | $175.72 |
Price | $110.45 |
Potential |
59.10%
register free of charge
|
Number of Estimates | 18 |
18 Analysts have issued a price target Jazz Pharmaceuticals Plc 2025 .
The average Jazz Pharmaceuticals Plc target price is $175.72.
This is
59.10%
register free of charge
$230.00
108.24%
register free of charge
$120.00
8.65%
register free of charge
|
|
A rating was issued by 20 analysts: 16 Analysts recommend Jazz Pharmaceuticals Plc to buy, 4 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Jazz Pharmaceuticals Plc stock has an average upside potential 2025 of
59.10%
register free of charge
|
Dec '23 |
2024 Estimates |
|
---|---|---|
Revenue Billion $ | 3.83 | 4.04 |
4.78% | 5.25% | |
EBITDA Margin | 33.85% | 44.99% |
8.21% | 32.90% | |
Net Margin | 9.82% | 11.91% |
262.62% | 21.23% |
18 Analysts have issued a sales forecast Jazz Pharmaceuticals Plc 2024 . The average Jazz Pharmaceuticals Plc sales estimate is
This results in the following potential growth metrics:
6 Analysts have issued an Jazz Pharmaceuticals Plc EBITDA forecast 2024. The average Jazz Pharmaceuticals Plc EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
8 Jazz Pharmaceuticals Plc Analysts have issued a net profit forecast 2024. The average Jazz Pharmaceuticals Plc net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '23 |
2024 Estimates |
|
---|---|---|
Earnings Per Share $ | 6.10 | 7.79 |
270.39% | 27.70% | |
P/E | 14.19 | |
EV/Sales | 2.63 |
8 Analysts have issued a Jazz Pharmaceuticals Plc forecast for earnings per share. The average Jazz Pharmaceuticals Plc <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2024, the Jazz Pharmaceuticals Plc stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
Jazz Pharmaceuticals Plc...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.